Overview
Publication Venue For
Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.
286:145-151.
2019
Clinical correlates and heritability of cardiac mechanics: The HyperGEN study.
274:208-213.
2019
Incidence and in-hospital outcomes of single-vessel coronary chronic total occlusion treated with percutaneous coronary intervention.
269:61-66.
2018
Comparison of carotid plaque burden among healthy middle-aged men living in the US, Japan, and South Korea.
266:245-249.
2018
Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
259:145-152.
2018
Glycogen synthase kinase 3β helps heart to pump better in obese patients.
259:166-167.
2018
FFR-guided multivessel stenting reduces urgent revascularization compared with infarct-related artery only stenting in ST-elevation myocardial infarction: A meta-analysis of randomized controlled trials.
252:63-67.
2018
Prognostic value of silent myocardial infarction in patients with chronic kidney disease being evaluated for kidney transplantation.
249:377-382.
2017
Treatment of systolic hypertension and low diastolic blood pressure in older adults: How low is too low?!.
242:21.
2017
Corrigendum to “Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the cardiovascular health study” [Int. J. Cardiol. 235 (2017) 11–16] (S0167527317312901) (10.1016/j.ijcard.2017.02.139)).
238:181.
2017
Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: Insights from the Cardiovascular Health Study.
238:140-143.
2017
Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
236:462-465.
2017
Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study.
235:11-16.
2017
Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
227:808-812.
2017
Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
227:462-466.
2017
Abnormal autonomic nervous system function in rural Thai men: A potential contributor to their high risk of sudden unexplained nocturnal death syndrome.
226:87-92.
2017
Catheter-directed treatment for acute pulmonary embolism: Systematic review and single-arm meta-analyses.
225:128-139.
2016
Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
221:1073-1080.
2016
Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies.
221:601-608.
2016
Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
220:122-128.
2016
What is the association of lipid levels and incident stroke?.
220:890-894.
2016
Relation of serum uric acid to cardiovascular disease.
213:4-7.
2016
Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy.
207:196-202.
2016
Depletion of cardiac 14-3-3η protein adversely influences pathologic cardiac remodeling during myocardial infarction after coronary artery ligation in mice.
202:146-153.
2016
Paroxysmal atrial fibrillation and the hazards of under-treatment.
202:214-220.
2016
Association between cumulative social risk and ideal cardiovascular health in US adults: NHANES 1999-2006.
191:296-300.
2015
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors - Results from a systematic review and meta-analysis of randomized controlled trials.
189:47-55.
2015
Coronary bifurcation lesions: Present status and future perspectives.
187:48-57.
2015
Glycoprotein IIb/IIIa inhibitors improve mortality after aspiration thrombectomy in patients with ST-segment elevation myocardial infarction.
187:206-207.
2015
Non-linear association of periodontal pathogen antibodies with mortality.
187:628-636.
2015
Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
185:219-223.
2015
Comparison between saddle versus non-saddle pulmonary embolism: Insights from nationwide inpatient sample.
180:58-59.
2015
Lack of "weekend effect" on mortality for pulmonary embolism admissions in 2011: Data from nationwide inpatient sample.
180:151-153.
2015
Analysis of vitamin D levels in patients with and without statin-associated myalgia - A systematic review and meta-analysis of 7 studies with 2420 patients.
178:111-116.
2015
One-year outcome following biological or mechanical valve replacement for infective endocarditis.
178:117-123.
2015
Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.
184:446-451.
2015
Success of left ventricular assist device therapy in uninsured patients.
177:1087-1088.
2014
Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart disease.
174:436-439.
2014
Beta-blockers in older patients with heart failure and preserved ejection fraction: Class, dosage, and outcomes.
173:393-401.
2014
Framingham score and LV mass predict events in young adults: CARDIA study.
172:350-355.
2014
Association of systolic blood pressure levels with cardiovascular events and all-cause mortality among older adults taking antihypertensive medication.
176:219-226.
2014
Racial differences in mortality in patients with advanced systolic heart failure: Potential role of right ventricular ejection fraction.
177:255-260.
2014
Anthrax lethal toxin induces acute diastolic dysfunction in rats through disruption of the phospholamban signaling network.
168:3884-3895.
2013
Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study.
168:3764-3769.
2013
Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: Findings from a population-based cohort study.
168:3616-3622.
2013
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: The NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
168:2335-2340.
2013
Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events.
168:1905-1909.
2013
Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytes.
168:436-445.
2013
Impact of diabetes on long-term mortality following multivessel percutaneous interventions: An insight into optimal statistical analysis.
167:2120-2125.
2013
Takotsubo cardiomyopathy versus ST-elevation myocardial infarction in a large case-control study: Proposing a New Mechanism.
167:1079-1081.
2013
Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: Insights from the SOLVD Treatment trial.
167:151-156.
2013
What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department? A clinical survey.
166:752-754.
2013
Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data.
166:230-235.
2013
Outcomes of patients with chronic kidney disease and implantable cardiac defibrillator: Primary versus secondary prevention.
165:113-116.
2013
Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving beta-blockers: Insights from the BEST trial.
163:61-67.
2013
The heart rate response to adenosine: A simple predictor of adverse cardiac outcomes in asymptomatic patients with type 2 diabetes.
167:2952-2957.
2013
Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: Findings from the Alabama Heart Failure Project.
162:39-44.
2012
Ventricular assist devices: Bridge to continued employment.
158:468.
2012
Circulating carboxy-terminal propeptide of type i procollagen is increased in rheumatic heart disease.
156:117-119.
2012
Right ventricular ejection fraction b20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.
155:120-125.
2012
The role of echocardiography in the evaluation and management of aortic stenosis in the older adult.
155:39-48.
2012
Outcomes in younger and older adults with chronic advanced systolic heart failure: A propensity-matched study.
154:128-133.
2012
High risk closure of a large secundum ASD causing platypnea-orthodeoxia.
152.
2011
Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.
151:69-75.
2011
Self-reported teenage body size and heart failure in adults ≥ 65 years of age.
149:401-402.
2011
Gender-related dissociation in outcomes in chronic heart failure: Reduced mortality but similar hospitalization in women.
148:36-42.
2011
Erratum: A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure (Int. J. Cardiol. (2009) 137 (1-8)).
145:409.
2010
Epidemiology of stroke in chronic heart failure patients with normal sinus rhythm: Findings from the DIG stroke sub-study.
144:389-393.
2010
Mild hyperkalemia and outcomes in chronic heart failure: A propensity matched study.
144:383-388.
2010
Higher levels of education may be a marker of higher disease-specific knowledge in patients with chronic heart failure.
144:93-94.
2010
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: A propensity-matched study of the EPHESUS trial.
143:309-316.
2010
Association between hyperuricemia and incident heart failure among older adults: A propensity-matched study.
142:279-287.
2010
Oral potassium supplement use and outcomes in chronic heart failure: A propensity-matched study.
141:167-174.
2010
Incident coronary revascularization and subsequent mortality in chronic heart failure: A propensity-matched study.
140:55-59.
2010
Erratum to "Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure" [Int. J. Cardiol. 134 (2009) 330-335] (DOI:10.1016/j.ijcard.2008.12.089).
138:106.
2010
A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.
137:1-8.
2009
Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched study.
136:270-277.
2009
Low-dose digoxin and reduction in mortality and morbidity in heart failure.
136:91-92.
2009
Aspirated air in the pericardial space during epicardial catheterization may elevate the defibrillation threshold.
135.
2009
Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: A propensity-matched study of multimorbidity in chronic heart failure.
134:330-335.
2009
Takotsubo cardiomyopathy - A new variant and widening disease spectrum. "Inverted takotsubo" pattern related to catecholamine toxicity.
132:438-439.
2009
A propensity matched study of the association of education and outcomes in chronic heart failure.
129:93-99.
2008
Richard Lower (1631-1691) and his early contributions to cardiology.
128:17-21.
2008
A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure.
125:246-253.
2008
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: A propensity-matched study of the DIG trial.
123:138-146.
2008
Takotsubo cardiomyopathy - A new variant and widening disease spectrum.
120.
2007
Restenosis is associated with decreased coronary artery nitric oxide synthase.
55:183-191.
1996
Exaggerated systolic blood pressure response to exercise: a normal variant or a hyperdynamic phase of essential hypertension?.
18:207-221.
1988
Prognostic implications of rest and exercise radionuclide ventriculography in patients with suspected or proven coronary heart disease.
6:707-718.
1984
